Caribou Biosciences (CRBU) Long-Term Investments (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Long-Term Investments data on file, last reported at $1.0 million in Q1 2026.

• On a quarterly basis, Long-Term Investments fell 89.2% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 89.2% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 62.21% from the prior year.
• Long-Term Investments for Q1 2026 stood at $1.0 million, down from $3.5 million in the prior quarter.
• Over the last five years, Long-Term Investments for CRBU reached as high as $69.4 million in Q4 2022 and fell as low as $132000.0 in Q2 2025.
• Historically, Long-Term Investments has averaged $23.5 million across 5 years, with a median of $9.3 million in 2024.
• Across the five-year window, Long-Term Investments soared 809.69% in 2022 and sank 99.73% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $69.4 million in 2022, then sank by 37.18% to $43.6 million in 2023, then sank by 78.71% to $9.3 million in 2024, then slumped by 62.21% to $3.5 million in 2025, then plunged by 71.44% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $1.0 million in Q1 2026, $3.5 million in Q4 2025, and $143000.0 in Q3 2025.